Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qing Tang

Showing results (1181-1190 of 1,268) with videos related to

Pageof 127
Sort By:
Combinatorial Chemistry & High Throughput Screening|April 20, 2026
Overexpression of ANAPC1 Affects the Cell Cycle Pathway to Promote the Progression of Lung AdenocarcinomaZhen Yang, Xiao-Song Chen, Yi-Yang Chen, et al.
Science Advances|April 16, 2025
Earlier onset of chemotherapy-induced neuropathic pain in females by ICAM-1-mediated accumulation of perivascular macrophagesLi Chen, Xin Zou, Cui-Cui Liu, et al.
Drug Design, Development and Therapy|September 24, 2014
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemiaHai-Fei Chen, Bin-Xian Xu, Hong-Shi Shen, et al.
Frontiers in Immunology|August 25, 2023
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Yi Chuan = Hereditas|October 23, 2023
Genomic prediction of pig growth traits based on machine learningDong Chen, Shu-Jie Wang, Zhen-Jian Zhao, et al.
Frontiers in Immunology|October 11, 2023
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Phytochemistry|September 14, 2023
Lindenane sesquiterpenoid dimers from Chloranthus holostegius with anti-neuroinflammatory activities in BV-2 microgliaZhao-Chun Zhan, Yi-Ping Xia, Qing Tang, et al.
Science Advances|April 9, 2025
Remove the innermost atom of a magnetic multi-shell gold nanoparticle for near-unity conversion of CO<sub>2</sub> to COGuoqing Bian, Dong Chen, Yuping Chen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 11, 2024
Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancerDong-Ming Li, Guo-Sheng Li, Jian-Di Li, et al.
BMC Cancer|June 1, 2025
Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trialYing Ying Wu, Lian Chen Lee, Hong Zeng, et al.
Pageof 127

Showing results (1181-1190 of 1,268) with videos related to

Sort By:
Pageof 127
Combinatorial Chemistry & High Throughput Screening|April 20, 2026
Overexpression of ANAPC1 Affects the Cell Cycle Pathway to Promote the Progression of Lung AdenocarcinomaZhen Yang, Xiao-Song Chen, Yi-Yang Chen, et al.
Science Advances|April 16, 2025
Earlier onset of chemotherapy-induced neuropathic pain in females by ICAM-1-mediated accumulation of perivascular macrophagesLi Chen, Xin Zou, Cui-Cui Liu, et al.
Drug Design, Development and Therapy|September 24, 2014
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemiaHai-Fei Chen, Bin-Xian Xu, Hong-Shi Shen, et al.
Frontiers in Immunology|August 25, 2023
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Yi Chuan = Hereditas|October 23, 2023
Genomic prediction of pig growth traits based on machine learningDong Chen, Shu-Jie Wang, Zhen-Jian Zhao, et al.
Frontiers in Immunology|October 11, 2023
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Phytochemistry|September 14, 2023
Lindenane sesquiterpenoid dimers from Chloranthus holostegius with anti-neuroinflammatory activities in BV-2 microgliaZhao-Chun Zhan, Yi-Ping Xia, Qing Tang, et al.
Science Advances|April 9, 2025
Remove the innermost atom of a magnetic multi-shell gold nanoparticle for near-unity conversion of CO<sub>2</sub> to COGuoqing Bian, Dong Chen, Yuping Chen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 11, 2024
Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancerDong-Ming Li, Guo-Sheng Li, Jian-Di Li, et al.
BMC Cancer|June 1, 2025
Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trialYing Ying Wu, Lian Chen Lee, Hong Zeng, et al.
Pageof 127